TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.

Steven G DuBois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.